£3.3M
The financing round was led by LAUNCHub Ventures and Kadmos Capital to fund the company's shift towards the diagnostics market.
GlycanAge
GlycanAge provides biological age tests using glycan biomarkers to support preventative healthcare.
£3.3MTotal raised
GlycanAge is a biotechnology firm that commercialises decades of research into glycan biomarkers to provide biological age tests. The company is transitioning its focus from longevity services toward the broader diagnostics market.
Categories
Founders
GL
Gordan Lauc
Chief Scientific Officer